Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2017 Filed Apr 4, 2017 21:34 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
GrantStock Option · Derivative | 150,268 | $78.05 Strike: $78.05 | $11,728,417.40 |
DisclosureSEC source: 0001127602-17-014048 · form4.xml · derivative · entry 5 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,268 Underlying: Common Stock · 150,268 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:34 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
GrantCommon Stock (restricted) | 19,218 | $78.05 | $1,499,964.90 |
DisclosureSEC source: 0001127602-17-014048 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,191 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:40 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
GrantStock Option · Derivative | 75,134 | $78.05 Strike: $78.05 | $5,864,208.70 |
DisclosureSEC source: 0001127602-17-014059 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,134 Underlying: Common Stock · 75,134 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:40 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
GrantCommon Stock (restricted) | 9,609 | $78.05 | $749,982.45 |
DisclosureSEC source: 0001127602-17-014059 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,486 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:39 UTC |
Denton David MEVP and CFO
|
GrantStock Option · Derivative | 100,179 | $78.05 Strike: $78.05 | $7,818,970.95 |
DisclosureSEC source: 0001127602-17-014057 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,179 Underlying: Common Stock · 100,179 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:39 UTC |
Denton David MEVP and CFO
|
GrantCommon Stock (restricted) | 12,812 | $78.05 | $999,976.60 |
DisclosureSEC source: 0001127602-17-014057 · form4.xml · nonDerivative · entry 3 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,877 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:43 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
GrantStock Option · Derivative | 55,098 | $78.05 Strike: $78.05 | $4,300,398.90 |
DisclosureSEC source: 0001127602-17-014066 · form4.xml · derivative · entry 6 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,098 Underlying: Common Stock · 55,098 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:43 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
GrantCommon Stock (restricted) | 7,046 | $78.05 | $549,940.30 |
DisclosureSEC source: 0001127602-17-014066 · form4.xml · nonDerivative · entry 3 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,084.0004 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:42 UTC |
GOLD STEPHEN JEVP & CIO
|
GrantStock Option · Derivative | 67,621 | $78.05 Strike: $78.05 | $5,277,819.05 |
DisclosureSEC source: 0001127602-17-014061 · form4.xml · derivative · entry 5 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,621 Underlying: Common Stock · 67,621 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:42 UTC |
GOLD STEPHEN JEVP & CIO
|
GrantCommon Stock (restricted) | 8,648 | $78.05 | $674,976.40 |
DisclosureSEC source: 0001127602-17-014061 · form4.xml · nonDerivative · entry 2 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,818 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:46 UTC |
Kraft Robert O.EVP and President - Omnicare
|
GrantStock Option · Derivative | 40,071 | $78.05 Strike: $78.05 | $3,127,541.55 |
DisclosureSEC source: 0001127602-17-014069 · form4.xml · derivative · entry 4 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,071 Underlying: Common Stock · 40,071 shares Expires 2024-04-03 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:46 UTC |
Kraft Robert O.EVP and President - Omnicare
|
GrantCommon Stock (restricted) | 5,124 | $78.05 | $399,928.20 |
DisclosureSEC source: 0001127602-17-014069 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,360 F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:48 UTC |
Sussman AndrewEVP, Clinical Services
|
GrantStock Option · Derivative | 37,567 | $78.05 Strike: $78.05 | $2,932,104.35 |
DisclosureSEC source: 0001127602-17-014072 · form4.xml · derivative · entry 5 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,567 Underlying: Common Stock · 37,567 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:48 UTC |
Sussman AndrewEVP, Clinical Services
|
GrantCommon Stock (restricted) | 4,804 | $78.05 | $374,952.20 |
DisclosureSEC source: 0001127602-17-014072 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,433 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:49 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
GrantStock Option · Derivative | 35,062 | $78.05 Strike: $78.05 | $2,736,589.10 |
DisclosureSEC source: 0001127602-17-014075 · form4.xml · derivative · entry 3 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,062 Underlying: Common Stock · 35,062 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:49 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 4,484 | $78.05 | $349,976.20 |
DisclosureSEC source: 0001127602-17-014075 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,674 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:52 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantStock Option · Derivative | 35,062 | $78.05 Strike: $78.05 | $2,736,589.10 |
DisclosureSEC source: 0001127602-17-014082 · form4.xml · derivative · entry 4 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,062 Underlying: Common Stock · 35,062 shares Expires 2024-04-03 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/3/2018. Read SEC document |
| April 03, 2017 Filed Apr 4, 2017 21:52 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantCommon Stock (restricted) | 4,484 | $78.05 | $349,976.20 |
DisclosureSEC source: 0001127602-17-014082 · form4.xml · nonDerivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,015 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/3/2020 and 50% on 4/3/2022. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:31 UTC |
MERLO LARRY JDirector · President and CEO
|
Tax withholdingCommon Stock | 19,944 | $78.50 | $1,565,604.00 |
DisclosureSEC source: 0001127602-17-014045 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,417.5612 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:32 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
Tax withholdingCommon Stock | 4,655 | $78.50 | $365,417.50 |
DisclosureSEC source: 0001127602-17-014046 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,812.1293 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:34 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Tax withholdingCommon Stock | 2,394 | $78.50 | $187,929.00 |
DisclosureSEC source: 0001127602-17-014048 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,996.6533 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:40 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 3,990 | $78.50 | $313,215.00 |
DisclosureSEC source: 0001127602-17-014059 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,068.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:39 UTC |
Denton David MEVP and CFO
|
Tax withholdingCommon Stock | 6,649 | $78.50 | $521,946.50 |
DisclosureSEC source: 0001127602-17-014057 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,562.8314 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:43 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
Tax withholdingCommon Stock | 1,862 | $78.50 | $146,167.00 |
DisclosureSEC source: 0001127602-17-014066 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,001 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:48 UTC |
Sussman AndrewEVP, Clinical Services
|
Tax withholdingCommon Stock | 1,596 | $78.50 | $125,286.00 |
DisclosureSEC source: 0001127602-17-014072 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,656 Read SEC document |
| April 02, 2017 Filed Apr 4, 2017 21:52 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
Tax withholdingCommon Stock | 1,862 | $78.50 | $146,167.00 |
DisclosureSEC source: 0001127602-17-014082 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,601 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:31 UTC |
MERLO LARRY JDirector · President and CEO
|
Tax withholdingCommon Stock | 12,906 | $78.50 | $1,013,121.00 |
DisclosureSEC source: 0001127602-17-014045 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,361.5612 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:37 UTC |
Moriarty Thomas MEVP & General Counsel
|
Tax withholdingCommon Stock | 2,617 | $78.50 | $205,434.50 |
DisclosureSEC source: 0001127602-17-014055 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,926.2875 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:40 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 2,097 | $78.50 | $164,614.50 |
DisclosureSEC source: 0001127602-17-014059 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,058.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:39 UTC |
Denton David MEVP and CFO
|
Tax withholdingCommon Stock | 2,420 | $78.50 | $189,970.00 |
DisclosureSEC source: 0001127602-17-014057 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,211.8314 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:43 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
Tax withholdingCommon Stock | 1,291 | $78.50 | $101,343.50 |
DisclosureSEC source: 0001127602-17-014066 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,863 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:42 UTC |
GOLD STEPHEN JEVP & CIO
|
Tax withholdingCommon Stock | 1,396 | $78.50 | $109,586.00 |
DisclosureSEC source: 0001127602-17-014061 · form4.xml · nonDerivative · entry 1 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,187.6785 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:48 UTC |
Sussman AndrewEVP, Clinical Services
|
Tax withholdingCommon Stock | 1,129 | $78.50 | $88,626.50 |
DisclosureSEC source: 0001127602-17-014072 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,252 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:49 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 2,705 | $78.50 | $212,342.50 |
DisclosureSEC source: 0001127602-17-014075 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,521.1476 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2017 Filed Apr 4, 2017 21:52 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
Tax withholdingCommon Stock | 847 | $78.50 | $66,489.50 |
DisclosureSEC source: 0001127602-17-014082 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,463 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 20:20 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 16,637 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-17-012624 · form4.xml · derivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,637 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 20:20 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
SaleCommon Stock | 7,212 | $78.73 | $567,800.76 |
DisclosureSEC source: 0001127602-17-012624 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,460.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $78.32 and $79.00 per share. Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 20:20 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
SaleCommon Stock | 16,637 | $78.73 | $1,309,831.01 |
DisclosureSEC source: 0001127602-17-012624 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,672.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $78.30 and $79.00 per share. Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 20:20 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Exercise / conversionCommon Stock | 16,637 | $45.07 | $749,829.59 |
DisclosureSEC source: 0001127602-17-012624 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,309.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2017 Filed Mar 20, 2017 20:24 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
Exercise / conversionStock Option · Derivative | 6,029 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-17-012396 · form4.xml · derivative · entry 4 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,029 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2012. Read SEC document |
| March 17, 2017 Filed Mar 20, 2017 20:24 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
SaleCommon Stock | 6,029 | $79.60 | $479,908.40 |
DisclosureSEC source: 0001127602-17-012396 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,585.1476 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 17, 2017 Filed Mar 20, 2017 20:24 UTC |
Boratto Eva CEVP, Cont & Chief Acct Officer
|
Exercise / conversionCommon Stock | 6,029 | $34.96 | $210,773.84 |
DisclosureSEC source: 0001127602-17-012396 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · EVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,614.1476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:21 UTC |
Sussman AndrewEVP, Clinical Services
|
Exercise / conversionStock Option · Derivative | 6,655 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-17-011593 · form4.xml · derivative · entry 6 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,655 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/2/2013. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:21 UTC |
Sussman AndrewEVP, Clinical Services
|
SaleCommon Stock | 7,449 | $80.40 | $598,899.60 |
DisclosureSEC source: 0001127602-17-011593 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,697 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:21 UTC |
Sussman AndrewEVP, Clinical Services
|
SaleCommon Stock | 6,655 | $80.40 | $535,062.00 |
DisclosureSEC source: 0001127602-17-011593 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,146 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 13, 2017 Filed Mar 14, 2017 20:21 UTC |
Sussman AndrewEVP, Clinical Services
|
Exercise / conversionCommon Stock | 6,655 | $45.07 | $299,940.85 |
DisclosureSEC source: 0001127602-17-011593 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 20:11 UTC |
Denton David MEVP and CFO
|
Exercise / conversionStock Option · Derivative | 95,618 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-17-011434 · form4.xml · derivative · entry 5 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 95,618 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 20:11 UTC |
Denton David MEVP and CFO
|
SaleCommon Stock | 95,618 | $80.68 | $7,714,460.24 |
DisclosureSEC source: 0001127602-17-011434 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,716.8314 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $80.40 and $81.00 per share. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 20:11 UTC |
Denton David MEVP and CFO
|
Exercise / conversionCommon Stock | 95,618 | $36.23 | $3,464,240.14 |
DisclosureSEC source: 0001127602-17-011434 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,334.8314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 21:14 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 155 | $80.58 | $12,489.90 |
DisclosureSEC source: 0001127602-17-009244 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,931.1476 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.